Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2025-12-26 @ 11:44 PM
Study NCT ID:
NCT04895566
Status:
COMPLETED
Last Update Posted:
2023-03-20
First Post:
2021-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma
Sponsor:
SWISS BIOPHARMA MED GmbH
Organization: